AlphaGrep UK’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$231K Sell
909
-156
-15% -$36.4K 0.07% 625
2026
Q1
$260K Sell
1,065
-497
-32% -$116K 0.08% 580
2025
Q4
$323K Buy
+1,562
New +$309K 0.11% 380

Other funds holding JNJ

AlphaGrep UK's JNJ Position: Q2 2026 in Review

AlphaGrep UK reduced its Johnson & Johnson (JNJ) stake by 15% in Q2 2026, selling an estimated $36.4K and leaving 909 shares worth $231K. The position accounts for 0.07% of the portfolio, ranked #625.

AlphaGrep UK first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. The position peaked at $323K in Q4 2025. 4,503 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • AlphaGrep UK held 909 shares of Johnson & Johnson worth $231K as of Q2 2026.
  • AlphaGrep UK sold 156 Johnson & Johnson shares in Q2 2026, an estimated $36.4K.
  • Johnson & Johnson made up 0.07% of AlphaGrep UK's portfolio in Q2 2026, its #625 holding.
  • AlphaGrep UK first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • AlphaGrep UK's Johnson & Johnson position peaked at $323K in Q4 2025.
  • 4,503 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.